Medindia

X

Pravastatin Launched by Watson Pharmaceuticals

by Medindia Content Team on  April 26, 2006 at 12:12 PM Drug News   - G J E 4
Pravastatin Launched by Watson Pharmaceuticals
Pravastatin sodium has been launched by Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, under a distribution agreement with Bristol-Myers Squibb Company. Shipments of pravastatin sodium tablets have been started by Watson, in the 10, 20 and 40 mg strengths.
Advertisement

Watson Pharmaceuticals, Inc. has its headquarters in Corona, CA. It is a leading specialty pharmaceutical company that specializes in the development, manufacture, marketing, and distribution of brand and generic pharmaceutical products. Watson owes its remarkable growth to the company's strategy of combining internal product development along with strategic alliances and synergistic acquisitions of products and businesses.

Advertisement
This Pravastatin sodium is the authorized generic version of Bristol-Myers Squibb's Pravachol(R) product. It consumption has been recommended along with the diet to decrease risks of first heart attack in patients with cardiovascular risks such as elevated cholesterol. It has also been recommended to prevent recurrent heart attack or a stroke in patients with cardiovascular disease especially when diet and exercise are not enough to reverse the symptoms of the disease.

In the year 2005 Pravachol(R) produced sales of approximately $1.7 billion, according to IMS Health data.
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: